Nature Communications (May 2016)

Inhibition of the hexosamine biosynthetic pathway promotes castration-resistant prostate cancer

  • Akash K. Kaushik,
  • Ali Shojaie,
  • Katrin Panzitt,
  • Rajni Sonavane,
  • Harene Venghatakrishnan,
  • Mohan Manikkam,
  • Alexander Zaslavsky,
  • Vasanta Putluri,
  • Vihas T. Vasu,
  • Yiqing Zhang,
  • Ayesha S. Khan,
  • Stacy Lloyd,
  • Adam T. Szafran,
  • Subhamoy Dasgupta,
  • David A. Bader,
  • Fabio Stossi,
  • Hangwen Li,
  • Susmita Samanta,
  • Xuhong Cao,
  • Efrosini Tsouko,
  • Shixia Huang,
  • Daniel E. Frigo,
  • Lawrence Chan,
  • Dean P. Edwards,
  • Benny A. Kaipparettu,
  • Nicholas Mitsiades,
  • Nancy L. Weigel,
  • Michael Mancini,
  • Sean E. McGuire,
  • Rohit Mehra,
  • Michael M. Ittmann,
  • Arul M. Chinnaiyan,
  • Nagireddy Putluri,
  • Ganesh S. Palapattu,
  • George Michailidis,
  • Arun Sreekumar

DOI
https://doi.org/10.1038/ncomms11612
Journal volume & issue
Vol. 7, no. 1
pp. 1 – 12

Abstract

Read online

The molecular alterations driving anti-androgen resistance in prostate cancer are unclear. Here, the authors show, using a network-based approach, that inhibition of the hexosamine biosynthetic pathway is necessary to develop resistance and that increasing the activity of the pathway enhances the anti-androgen response.